raloxifene hydrochloride has been researched along with chitosan in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, J; Ali, MM; Baboota, S; Fazil, M; Saini, D | 1 |
| Majdejabbari, S; Mohammadi, Z; Samadi, FY; Yousefi, M | 1 |
| Cheng, J; Feng, X; Xiao, YC; Yin, RF; Zhang, ML | 1 |
| Rajput, SJ; Shah, PV | 1 |
| Abd-Rabou, AA; Almutairi, FM; Mohamed, MS | 1 |
| Abdel-Salam, FS; Amer, MS; Basalious, EB; Elkasabgy, NA; Elkheshen, SA; Mahmoud, AA; Mostafa, AA | 1 |
| Baby, T; Bulbule, A; Gorain, M; Kundu, GC; Radharani, NNV; Roy, G; Shetti, D; Yadav, AS | 1 |
| Mohammadi, Z; Rahmani, S; Samadi, FY | 1 |
| Kathuria, H; Murthy, A; Ravi, PR; Vats, R | 1 |
| Ashrafzadeh Afshar, E; Jin, X; Joo, SW; Mashifana, T; Taher, MA; Vasseghian, Y; Wu, Y; Xia, C | 1 |
10 other study(ies) available for raloxifene hydrochloride and chitosan
| Article | Year |
|---|---|
Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Topics: Administration, Intranasal; Administration, Oral; Animals; Area Under Curve; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Liberation; Drug Stability; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Nanoparticles; Osteoporosis, Postmenopausal; Particle Size; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators | 2015 |
Synthesis of raloxifene-chitosan conjugate: A novel chitosan derivative as a potential targeting vehicle.
Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Molecular Structure; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Thermogravimetry | 2016 |
Raloxifene microsphere-embedded collagen/chitosan/β-tricalcium phosphate scaffold for effective bone tissue engineering.
Topics: Animals; Bone Density Conservation Agents; Calcium Phosphates; Cell Line; Cell Survival; Chitosan; Collagen; Lactic Acid; Mice; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tissue Engineering; Tissue Scaffolds | 2017 |
Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride.
Topics: Bone Density Conservation Agents; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Porosity; Raloxifene Hydrochloride; Silicon Dioxide | 2018 |
Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Humans; Hyaluronic Acid; Lung Neoplasms; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Raloxifene Hydrochloride | 2019 |
In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model.
Topics: Animals; Bone Density Conservation Agents; Bone Regeneration; Chitosan; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Implants; Glass; Male; Nanoparticles; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Treatment Outcome | 2020 |
RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Oligopeptides; Raloxifene Hydrochloride; Tumor Microenvironment | 2020 |
Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Humans; MCF-7 Cells; Nanoparticles; Raloxifene Hydrochloride; Receptors, Estrogen | 2020 |
Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene.
Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Carriers; Female; Lecithins; Nanoparticles; Particle Size; Raloxifene Hydrochloride; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2020 |
Simple turn-off fluorescence sensor for determination of raloxifene using gold nanoparticles stabilized by chitosan hydrogel.
Topics: Chitosan; Gold; Hydrogels; Metal Nanoparticles; Raloxifene Hydrochloride; Spectroscopy, Fourier Transform Infrared | 2022 |